Semax — 10 mg

Description

Semax is a synthetic heptapeptide analogue of the ACTH(4-10) fragment with a Pro-Gly-Pro extension (Met-Glu-His-Phe-Pro-Gly-Pro), developed at the Institute of Molecular Genetics (Russia). It was previously approved in Russia for certain neurological indications and is supplied here solely as a lyophilized research chemical.

Research context: In published laboratory and preclinical research, Semax has been studied in the context of neurotrophic (BDNF, NGF) signaling and neuroprotection pathways.

Specifications: Sequence Met-Glu-His-Phe-Pro-Gly-Pro; molecular mass 813.92 Da; purity 99.08% (HPLC); 10 mg lyophilized powder in a sealed vial; storage 2–8°C.

This product is supplied strictly for in-vitro laboratory research. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or animal consumption, medical, veterinary, or household use.